Benefit-risk analyses in cancer treatment
From frustration to innovation: Marc Buyse's mission with One2Treat
One2Treat launches groundbreaking treatment-decision approach to clinical research and market access analysis
Improving knowledge about the treatment effect
Design a patient-centric trial & avoid a demonstration of "non-inferiority"
Benefit-risk assessment for metastatic pancreatic cancer
Mid-size US biotech company, phase 3 oncology trial
Using more information for fewer patients.
Including patient voice in therapeutic choices in breast cancer care.
.png)
